Clinical TrialsSearch results
Number of results: 213
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Intravenous liposomal amphotericin B versus intravenous voriconazole for chronic pulmonary aspergillosis: a multicenter, open-labeled trial in Japan
- Chronic pulmonary aspergillosis
- NEOCI (Nagasaki Evaluation Organization for Clinical Interventions)
- 2009-07-22
Completed
- A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines
- Chronic Spontaneous Urticaria
- Maruyama Hideki
- 2021-12-26
Other
- Randomized Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary
- clear cell carcinoma of the ovary
- Japanese Gynecologic Oncology Group
- 2006-10-10
Other
- Phase II trial of endoscopic submucosal dissection to expand indication for early gastric cancer (JCOG0607)
- clinical T1 gastric cancer without submucosal invasion
- Japan Clinical Oncology Group (JCOG)
- 2007-06-08
Completed
- Dupilumab for the treatment of chronic inducible cold urticaria in patients who remain symptomatic despite the use of H1-antihistamine
- Cold Urticaria
- Tanaka Tomoyuki
- 2021-03-18
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery
(a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10